Andreas Wallnoefer
Director/Miembro de la Junta en Eyebiotech Ltd. .
Cargos activos de Andreas Wallnoefer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Eyebiotech Ltd.
 Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Director/Miembro de la Junta | - | - |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Inversor de Capital Privado | 01/10/2021 | - |
Historial de carrera de Andreas Wallnoefer
Estadísticas
Internacional
| Reino Unido | 2 |
| Francia | 2 |
Operativa
| Director/Board Member | 1 |
| Private Equity Investor | 1 |
Sectorial
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital SASU (Jeito Capital) is an Independent Venture Capital firm founded in 2018 by Rafaele Tordjman and headquartered in Paris, France. | Finance |
- Bolsa de valores
- Insiders
- Andreas Wallnoefer
- Experiencia
